title: Stimulative effects of saponin from kikyo-to, a Japanese herbal medicine, on pancreatic exocrine secretion of conscious rats.
abstract: Our previous report stated that kikyo-to, a Japanese herbal medicine, consisting of the roots of Platycodon grandiflorum and Glycyrrhiza sp., stimulates the pancreatic exocrine secretion of conscious rats. The present study focused on the effective components of kikyo-to and the mechanism of stimuli to pancreatic secretion of rats. When 10 to 100 mg of platycodin D, a saponin from the root of Platycodon grandiflorum, was intragastrically administered, the pancreatic secretion of rats was stimulated. At the same time, the plasma CCK concentration increased. On the other hand, the stimulative effects of glycyrrhizin, a saponin from the root of Glycyrrhiza sp. were weak compared to platycodin D. The effects of 10 mg/kg of platycodin D on pancreatic secretion were inhibited by loxiglumide (50 mg/kg, i.g.), a CCK receptor antagonist. In contrast, the suppressive effect of atropine (300 micrograms/kg/h, i.v.) on pancreatic secretion was reduced by administering 10 mg/kg of platycodin D. In addition, up to 1 mM of platycodin D did not inhibit the trypsin activities in vitro. In conclusion, kikyo-to serves to stimulate pancreatic exocrine secretion mainly because platycodin D causes gastrointestinal hormones, particularly, CCK to be released from the duodenum.
authors.affiliation: Central Research Laboratories, Tsumura & Co., Ibaraki, Japan.
authors.forename: I
authors.initials: I
authors.lastname: Arai
authors.forename: Y
authors.initials: Y
authors.lastname: Komatsu
authors.forename: Y
authors.initials: Y
authors.lastname: Hirai
authors.forename: K
authors.initials: K
authors.lastname: Shingu
authors.forename: Y
authors.initials: Y
authors.lastname: Ida
authors.forename: H
authors.initials: H
authors.lastname: Yamaura
authors.forename: T
authors.initials: T
authors.lastname: Yamamoto
authors.forename: Y
authors.initials: Y
authors.lastname: Kuroiwa
authors.forename: K
authors.initials: K
authors.lastname: Sasaki
authors.forename: S
authors.initials: S
authors.lastname: Taguchi
mesh_terms: D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002766:Cholecystokinin / Q000378:metabolism; D004386:Duodenum / Q000502:physiology; D004952:Esters; D016670:Gabexate / Q000031:analogs & derivatives*; D019695:Glycyrrhizic Acid / Q000494:pharmacology; D006146:Guanidines / Q000494:pharmacology; D007564:Japan; D008297:Male; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism*; D010189:Pancreatic Juice / Q000187:drug effects / Q000378:metabolism*; D010936:Plant Extracts; D018517:Plant Roots; D010946:Plants, Medicinal; D011377:Proglumide / Q000031:analogs & derivatives / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors; D012503:Saponins / Q000302:isolation & purification / Q000494:pharmacology*; D014315:Triterpenes; D014357:Trypsin / Q000378:metabolism; D014361:Trypsin Inhibitors / Q000494:pharmacology
chemical_list: D004952:Esters; D006146:Guanidines; D010936:Plant Extracts; D011949:Receptors, Cholecystokinin; D012503:Saponins; D014315:Triterpenes; D014361:Trypsin Inhibitors; C008936:platycodin; C034532:camostat; D016670:Gabexate; D019695:Glycyrrhizic Acid; C053737:loxiglumide; D001285:Atropine; D002766:Cholecystokinin; C108953:platycodin D; D014357:Trypsin; D011377:Proglumide